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1392 Nakamura et al May 2014DISCUSSIONDr Nicolas A. Nelken (Honolulu, Hawaii). One of the great
things about reviewing a paper from another country is trying to
make sense of the differences in practice. Two to three percent
of Japanese dialysis patients undergo a procedure most of us
have never even heard of. That’s almost 9000 patients.
Are the differences historical, cultural, or physiological? His-
torical? Is this just a geographical product of the “see one, do
one, teach one” tradition in spite of worldwide instantaneous ac-
cess to information? Is it cultural? From the patient point of
view, it is highly unlikely that any patient would demand this
over a graft in my practice. Or from the doctor’s point of view,
it is unlikely that we would choose this procedure for an ejection
fraction of 40%, might be more likely at 30%, and would be a
good idea to explore at 25%. Or is it physiologic differences be-
tween populations? I had to laugh when I read that the average
body mass index (BMI) of Dr Nakamura’s patients was 19.1.
We don’t even operate in the same universe! That’s not Japan.
that’s Heaven!
So I think this new procedure shows promise, but. how do
we make sense of this for ourselves?
Let’s look at the individual indications from least likely to be
helpful to the most. I think it makes little sense to use this for pa-
tients with poor peripheral venous anatomy. If you can’t ﬁnd a vein
for a ﬁstula, how will you ﬁnd a vein for outﬂow? It makes a little
more sense to explore for those patients with congestive heart fail-
ure. I’m just not sure of the threshold. I’m yet more interested for
patients with central venous occlusion. The most interesting indi-
cation for me is for steal syndrome. Since we’ve already failed and
endangered the nondominant hand, it is good to know we have
another procedure to try before risking and jumping to the domi-
nant hand.
So, with this in mind, I have the following questions to help
resolve this: (1) At what BMI should we forget about it? Or is
this a depth issue that can be measured with ultrasound? (2)
How do patients tolerate the outﬂow during 4-hour dialysis runs
when they have central obstruction? (3) And ﬁnally, in my opinion,
the weak link in dialysis access care in America is at the technician
level. With a 4-year arterial failure rate of 40%, please excuse me
from being a little nervous. What can you tell me to allay my fears?
Dr Takashi Nakamura. Dr Nelken, thank you for your
thoughtful comments.
I would like to address your questions about BMI and the
depth of the artery. Data from the OECD (Organization for Eco-
nomic Cooperation and Development) show that individuals witha BMI over 25, which is considered to be obese, comprise only 3%
of the population in Japan as compared to 35% in the U.S. There-
fore, even though our cohort is thin, it is not an unusual represen-
tation in Japan.
Prior to surgery, we estimate the depth and elasticity of the
brachial artery in a physical examination and then perform an ultra-
sound examination with a tourniquet placed to verify the existence
of robust veins for return sites. In addition, we also evaluate the
brachial artery for diameter, degree of atherosclerosis, degree of
calciﬁcation, and anatomical variations, such as highly bifurcated
type or not and depth from the skin. We have not determined
exact criteria for depth because we rarely encounter obese patients.
To apply our method in obese patients, I would recommend a
lipectomy with a longer incision, which might create enough
length for cannulation, though I have not attempted that.
As for venous hypertension with central vein occlusion, it is
basically associated with a high blood ﬂow state, over 3000 to
4000 mL/min, which eventually requires banding or ligation of
the arteriovenous ﬁstula. However, if superﬁcialization of the
brachial artery is performed, the dilated artery as well as the dilated
returning vein can still be used as access sites. During a dialysis ses-
sion, average blood ﬂow is kept lower than 250 mL/min in Japan,
which is far less than with a patent arteriovenous ﬁstula. In fact,
venous pressure is constantly lower than 150 mm Hg; thus, central
venous occlusion is not a problem. Furthermore, even if blood
ﬂow is increased to 400 mL/min, I don’t think that venous hyper-
tension during a dialysis session will be a problem.
Close cooperation among the attending nephrologists and
dialysis staff regarding the unique characteristics of this particular
vascular access (VA) is essential to prevent serious complications.
Local hematoma formation or a minor infection at the site of punc-
ture related to inappropriate hemostasis by inexperienced
personnel should be avoided. I am sure that you will understand
how our method works after you attempt it. In fact, this VA has
been utilized in appropriately selected Japanese hemodialysis pa-
tients for more than 20 years with very satisfactory results.
Finally, a tunneled central venous catheter is generally used in
patients with severe heart disease for long-term dialysis. The per-
centage of patients using a catheter has increased in most countries
in recent years, even though tunneled central venous catheters are
prone to infection, stenosis, and thrombosis of the central veins,
and are not considered to represent an acceptable long-term alter-
native. Therefore, I recommend that this VA be considered before
indwelling central venous catheters.
